Royal Philips (PHG) Earnings Preview: What to Watch Before the Open

Royal Philips is set to report before the opening bell on July 28, 2026, and the quarter carries unusual weight given the ongoing FDA consent decree that has constrained its sleep and respiratory care business. That segment has been the central question mark for investors since the regulatory action, and any signal of recovery momentum in the results could meaningfully shift the outlook for the company's most scrutinized division.

The consent decree has limited Philips's ability to operate freely in one of its core markets, making each earnings release a closely watched data point on whether the company is regaining its regulatory footing. A quarter that demonstrates credible progress could reset investor expectations in a meaningful way, while a disappointing update would likely extend uncertainty around the timeline for a full return to normal operations.

The July 28 report is confirmed as a before-market-open release, though a specific time has not been disclosed. Investors will be watching not just the headline numbers but management's commentary on the pace of remediation and any forward guidance tied to the sleep and respiratory care recovery.